ATE126060T1 - Nucleoside und nucleotide mit antiviraler, antitumoraler, antimetastatischer sowie immunstimulierender wirkung. - Google Patents

Nucleoside und nucleotide mit antiviraler, antitumoraler, antimetastatischer sowie immunstimulierender wirkung.

Info

Publication number
ATE126060T1
ATE126060T1 AT88908566T AT88908566T ATE126060T1 AT E126060 T1 ATE126060 T1 AT E126060T1 AT 88908566 T AT88908566 T AT 88908566T AT 88908566 T AT88908566 T AT 88908566T AT E126060 T1 ATE126060 T1 AT E126060T1
Authority
AT
Austria
Prior art keywords
immunstimulative
antimetastatic
antitumoral
nucleosides
antiviral
Prior art date
Application number
AT88908566T
Other languages
English (en)
Inventor
Roland Kenith Robins
Howard Brinkerhoff Cottam
Original Assignee
Univ Brigham Young
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/136,020 external-priority patent/US4880784A/en
Application filed by Univ Brigham Young filed Critical Univ Brigham Young
Application granted granted Critical
Publication of ATE126060T1 publication Critical patent/ATE126060T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/24—Heterocyclic radicals containing oxygen or sulfur as ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT88908566T 1987-12-21 1988-09-02 Nucleoside und nucleotide mit antiviraler, antitumoraler, antimetastatischer sowie immunstimulierender wirkung. ATE126060T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/136,020 US4880784A (en) 1987-12-21 1987-12-21 Antiviral methods utilizing ribofuranosylthiazolo[4,5-d]pyrimdine derivatives
US07/236,366 US5041426A (en) 1987-12-21 1988-08-25 Immune system enhancing 3-β-d-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and nucleotides

Publications (1)

Publication Number Publication Date
ATE126060T1 true ATE126060T1 (de) 1995-08-15

Family

ID=26833912

Family Applications (2)

Application Number Title Priority Date Filing Date
AT94112331T ATE173929T1 (de) 1987-12-21 1988-09-02 7-thia-guanosin-derivate mit antiviraler, antitumoraler, antimetastatischer und immunstimulierender wirkung
AT88908566T ATE126060T1 (de) 1987-12-21 1988-09-02 Nucleoside und nucleotide mit antiviraler, antitumoraler, antimetastatischer sowie immunstimulierender wirkung.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT94112331T ATE173929T1 (de) 1987-12-21 1988-09-02 7-thia-guanosin-derivate mit antiviraler, antitumoraler, antimetastatischer und immunstimulierender wirkung

Country Status (11)

Country Link
US (1) US5041426A (de)
EP (2) EP0348446B1 (de)
JP (1) JP2590248B2 (de)
KR (1) KR970002611B1 (de)
AR (1) AR246104A1 (de)
AT (2) ATE173929T1 (de)
CA (1) CA1319931C (de)
DE (2) DE3856279T2 (de)
DK (1) DK406389A (de)
ES (1) ES2010786A6 (de)
WO (1) WO1989005649A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166141A (en) * 1983-11-01 1992-11-24 Scripps Clinic And Research Foundation Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-oxo-analogs of 8-substituted-guanine-9-(1'-beta-D-aldoglycosidyl) derivatives and methods of treating test animals
JPH04501254A (ja) * 1988-05-23 1992-03-05 アメリカ合衆国 癌治療剤としてのサイクリックａｍｐ誘導体
SK284054B6 (sk) * 1996-10-16 2004-08-03 Icn Pharmaceuticals, Inc. Substituované triazolové nukleozidy, farmaceutický prostriedok s ich obsahom a ich použitie
AU727177B2 (en) * 1996-10-16 2000-12-07 Icn Pharmaceuticals, Inc. Purine L-nucleosides, analogs and uses thereof
US6509320B1 (en) * 1996-10-16 2003-01-21 Icn Pharmaceuticals, Inc. Purine L-nucleosides, analogs and uses thereof
EP1103559A1 (de) * 1997-01-17 2001-05-30 ICN Pharmaceuticals, Inc. Autoimmun-Nukleoside
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
US6645990B2 (en) * 2000-08-15 2003-11-11 Amgen Inc. Thiazolyl urea compounds and methods of uses
US7321033B2 (en) * 2001-11-27 2008-01-22 Anadys Pharmaceuticals, Inc. 3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
WO2003045968A1 (en) * 2001-11-27 2003-06-05 Anadys Pharmaceuticals, Inc. 3-β-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
EP1667694B1 (de) 2003-09-05 2010-04-28 Anadys Pharmaceuticals, Inc. Tlr7-liganden zur behandlung von hepatitis c
CN1845745B (zh) * 2003-09-05 2011-11-02 安那迪斯药品股份有限公司 Tlr7配体及其前药在制备用于治疗丙型肝炎病毒感染的药物中的用途
GB0500020D0 (en) 2005-01-04 2005-02-09 Novartis Ag Organic compounds
AU2004320625B2 (en) * 2004-06-07 2009-08-27 Anadys Pharmaceuticals, Inc. 3-beta-D-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereof
ES2459368T3 (es) * 2004-12-17 2014-05-09 Anadys Pharmaceuticals, Inc. Compuestos de 3H-oxazolo y 3H-tiazolo[4,5-d]pirimidin-2-ona 3,5-disustituidos y 3,5,7-trisustituidos y profármacos de los mismos
CN101212968B (zh) * 2004-12-17 2011-11-16 安那迪斯药品股份有限公司 3,5-二取代的和3,5,7-三取代的-3H-噁唑并以及3H-噻唑并[4,5-d]嘧啶-2-酮化合物及其前药
CA2630463C (en) * 2005-11-21 2015-01-06 Anadys Pharmaceuticals, Inc. Novel process for the preparation of 5-amino-3h-thiazolo[4,5-d]pyrimidin-2-one
EP2518079A3 (de) 2006-04-11 2012-12-12 Novartis AG HCV/HIV-Hemmer und Benutzung davon
CA2655904C (en) * 2006-06-22 2014-11-18 Anadys Pharmaceuticals, Inc. Prodrugs of 5-amino-3-(3'-deoxy-.beta.-d-ribofuranosyl)-thiazolo[4,5-d]pyrimidin-2,7-dione
EP2040712B1 (de) * 2006-07-18 2011-03-02 Anadys Pharmaceuticals, Inc. Carbonat- und carbamat-prodrugs von thiazolo [4,5-d]-pyrimidinen
KR100880298B1 (ko) 2006-12-06 2009-01-28 애나디스 파마슈티칼스, 인코포레이티드 ３-β-Ｄ-리보푸라노실티아졸로[４,５-ｄ]피리미딘뉴클레오시드 및 이의 용도
UY32306A (es) 2008-12-09 2010-07-30 Gilead Sciences Inc Derivados de pteridinona y pirimidinodiazepinona y composiciones farmacéuticas que modulan en forma selectiva los receptores tipo toll, métodos y usos
US20110182850A1 (en) 2009-04-10 2011-07-28 Trixi Brandl Organic compounds and their uses
US8512690B2 (en) 2009-04-10 2013-08-20 Novartis Ag Derivatised proline containing peptide compounds as protease inhibitors
AP2012006535A0 (en) 2010-03-31 2012-10-31 Gilead Pharmasset Llc Stereoselective synthesis of phosphorous containing actives
CN103179966B (zh) 2010-10-08 2017-03-15 诺瓦提斯公司 磺酰胺ns3抑制剂的维生素e制剂
JPWO2012102366A1 (ja) * 2011-01-28 2014-06-30 日本たばこ産業株式会社 新規ピペラジン化合物の製造方法
SI3166607T1 (sl) 2014-07-11 2023-01-31 Gilead Sciences, Inc. Modulatorji toličnih receptorjev za zdravljenje HIV-a
CN110305133A (zh) 2014-09-16 2019-10-08 吉利德科学公司 Toll样受体调节剂的固体形式
HUE053704T2 (hu) * 2014-12-08 2021-07-28 Hoffmann La Roche 3-szubsztitutált 5-amino-6H-tiazolo[4,5-d]pirimidin-2,7-dion vegyületek vírusfertõzések kezelésére és megelõzésére
CN107427514B (zh) 2015-03-16 2021-07-13 豪夫迈·罗氏有限公司 使用tlr7激动剂和hbv衣壳装配抑制剂的组合治疗
EP3294745B1 (de) 2015-05-08 2020-01-01 H. Hoffnabb-La Roche Ag Neuartige oxathiolan-carbonsäuren und derivate zur behandlung und prophylaxe von virusinfektionen
CN107592864B (zh) 2015-05-12 2021-04-16 豪夫迈·罗氏有限公司 用于治疗和预防病毒感染的新的取代的氨基噻唑并嘧啶二酮
CN107820498B (zh) 2015-06-30 2020-06-19 豪夫迈·罗氏有限公司 用于治疗和预防病毒感染的取代的氨基噻唑并嘧啶二酮
WO2018127525A1 (en) 2017-01-06 2018-07-12 F. Hoffmann-La Roche Ag PROCESS FOR THE PREPARATION OF 3-SUBSTITUTED 5-AMINO-6H-THIAZOLO[4,5-d]PYRIMIDINE-2,7-DIONE COMPOUNDS
CN113924114A (zh) 2019-05-22 2022-01-11 吉利德科学公司 Tlr7调节化合物和hiv疫苗的组合

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166141A (en) * 1983-11-01 1992-11-24 Scripps Clinic And Research Foundation Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-oxo-analogs of 8-substituted-guanine-9-(1'-beta-D-aldoglycosidyl) derivatives and methods of treating test animals
US4746651A (en) * 1983-11-01 1988-05-24 Scripps Clinic And Research Foundation Antimicrobial chemotherapeutic potentiation using substituted nucleoside derivatives

Also Published As

Publication number Publication date
US5041426A (en) 1991-08-20
DK406389A (da) 1989-10-04
DE3854297D1 (de) 1995-09-14
WO1989005649A1 (en) 1989-06-29
KR970002611B1 (en) 1997-03-06
DE3856279D1 (de) 1999-01-14
AR246104A1 (es) 1994-03-30
EP0636372A1 (de) 1995-02-01
JP2590248B2 (ja) 1997-03-12
EP0348446B1 (de) 1995-08-09
ES2010786A6 (es) 1989-12-01
ATE173929T1 (de) 1998-12-15
DK406389D0 (da) 1989-08-18
KR900700106A (ko) 1990-08-11
JPH03504122A (ja) 1991-09-12
EP0636372B1 (de) 1998-12-02
EP0348446A4 (en) 1991-09-25
CA1319931C (en) 1993-07-06
DE3856279T2 (de) 1999-05-20
EP0348446A1 (de) 1990-01-03
DE3854297T2 (de) 1996-03-28

Similar Documents

Publication Publication Date Title
DE3854297D1 (de) Nucleoside und nucleotide mit antiviraler, antitumoraler, antimetastatischer sowie immunstimulierender wirkung.
DE3852682D1 (de) Therapeutische Nucleoside.
FI870977A7 (fi) Karbosykliset puriininukleosidit, niiden valmistus ja käyttö.
ATE44464T1 (de) Antivirale nukleoside.
DE3887226D1 (de) Nahrungsmittel, angereichert mit einem Gehalt an Nukleosiden und/oder Nukleotiden und ihre Herstellung.
DE3780581D1 (de) Antiviralen phosphonomethoxyalkylen-purin- und -pyrimidin-derivate.
DE3765045D1 (de) Fluorierte nucleoside, ihre herstellung und ihre pharmazeutische verwendung gegen aids.
FI932870A7 (fi) 2'-deoksi-2'2'-difluori-(4-substituoitu pyrimidiini)nukleosidejä, joilla on virusvastaista ja syöpävastaista aktiivisuutta, sekä välituotteita
FI893113A7 (fi) Terapeutiska nukleosider.
FI862011L (fi) Terapeutiska nukleosider.
FI920197A7 (fi) Viruksenvastaisia pyrimidiininukleosidejä
WO1993017651A3 (de) Antivirale nucleosidanaloge, ihre herstellung und ihre verwendung
IE900275L (en) Antivirals and methods of increasing the antiviral activity¹of azt
FI870377L (fi) Antivirala kompositioner.
NO932287D0 (no) 2'-deoksy-2',2'-difluor(2,6,8-substituerte) purine nukleosider med antiviral- og anticanceraktivitet, og mellomprodukter
DK630589A (da) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor-sammensaetning
DE68914750D1 (de) Therapeutische Nucleoside.
DE68918215D1 (de) 2'-Halomethyliden, 2'-Ethenyliden und 2'-Ethynyl-Adenosinderivate.
ZA892284B (en) Novel fluorophosphonate nucleotide derivatives
NO891835D0 (no) Prodrug-former av 2',3'-didehydro-2',3'-dideoksy-nukleosider.
FI870873A7 (fi) Isoheksidi-nukleosidi.
EP0335770A3 (de) Derivate von Fluorphosphonat-Nukleotiden
KR900700498A (ko) 항종양 6-술펜아미드, 6-술핀아미드 및 6-술폰아미드퓨린, 퓨린 뉴클레오시드, 퓨린 뉴클레오티드 및 관련 화합물
DE3875835D1 (de) Antivirale, antitumoraktive und fungizide zusammensetzungen.
FI870547A7 (fi) Karbosykliset puriini-nukleosidit, niiden valmistus ja käyttö.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time